Search Results - "Cui, Zhanglin"

Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States by Chen, Lei, Nelson, David R, Zhao, Yang, Cui, Zhanglin, Johnston, Joseph A

“…Loss of muscle mass and muscle strength are natural consequences of the aging process, accompanied by an increased prevalence of chronic health conditions…”
Get full text

A Simulation-Based Evaluation of Statistical Methods for Hybrid Real-World Control Arms in Clinical Trials by Shan, Mingyang, Faries, Douglas, Dang, Andy, Zhang, Xiang, Cui, Zhanglin, Sheffield, Kristin M.

“…Real-world (RW) data have been a source for creating external control arms to evaluate results from randomized controlled trials (RCTs) in rare diseases and…”
Get full text

Association of baseline symptom burden with efficacy outcomes: Exploratory analysis from the randomized phase III REVEL study in advanced non-small-cell lung cancer by Pérol, Maurice, Winfree, Katherine B., Cuyun Carter, Gebra, Lin Cui, Zhanglin, Bowman, Lee, Garon, Edward B.

“…•In REVEL, ramucirumab-docetaxel improved efficacy without detriment to QoL.•We explored the association between symptom burden and efficacy for advanced…”
Get full text

Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices by Paulson, A. Scott, Hess, Lisa M., Liepa, Astra M., Cui, Zhanglin Lin, Aguilar, Kathleen M., Clark, Jamyia, Schelman, William

“…Background Limited real-world research has investigated ramucirumab for the treatment of patients with gastric or gastroesophageal junction (GEJ) cancer. This…”
Get full text

Treatment heterogeneity and overall survival in patients with advanced/metastatic gastric or gastroesophageal junction adenocarcinoma in the United States by Davis, Jessica A., Cui, Zhanglin Lin, Ghias, Madiha, Li, Xiaohong, Goodloe, Robert, Wang, Chunxiao, Liepa, Astra M., Hess, Lisa M.

“…BackgroundGastric or gastroesophageal junction (GEJ) adenocarcinoma is the most common form of gastric cancer diagnosed in the United States (US) each year…”
Get full text

Application and comparison of generalized propensity score matching versus pairwise propensity score matching by Cui, Zhanglin L, Hess, Lisa M, Goodloe, Robert, Faries, Doug

“…A comparison of conventional pairwise propensity score matching (PSM) and generalized PSM method was applied to the comparative effectiveness of multiple…”
Get full text

The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer by Hess, Lisa M., Smith, David, Cui, Zhanglin L., Montejano, Leslie, Liepa, Astra M., Schelman, William, Bowman, Lee

“…The ability of a patient to receive anti-cancer treatment depends on a variety of factors, including performance status (PS), which is typically measured using…”
Get full text

Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practice by Molife, Cliff, Hess, Lisa M, Cui, Zhanglin Lin, Li, Xiaohong Ivy, Beyrer, Julie, Mahoui, Malika, Oton, Ana B

“…To describe treatment patterns and outcomes for advanced/metastatic non-small-cell lung cancer (aNSCLC) treated with single-agent or combination ramucirumab…”
Get full text

Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA by Hess, Lisa M., Cui, Zhanglin Lin, Mytelka, Daniel S., Han, Yimei, Goodloe, Robert, Schelman, William

“…Background Colorectal cancer is the third most common cause of cancer death in the USA. It is important to identify patients who may experience poor outcomes…”
Get full text

Treatment patterns in alpha-blocker therapy for benign prostatic hyperplasia by Schoenfeld, Michael J, Shortridge, Emily F, Gelwicks, Steven C, Cui, Zhanglin, Wong, David G

“…This study examined treatment patterns and patient characteristics of men initiating alpha adrenergic blocker therapy (alpha-blocker) for benign prostatic…”
Get full text

Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer by Aggarwal, Himani, Han, Yimei, Sheffield, Kristin M, Cui, Zhanglin Lin

“…This real-world study aims to compare overall survival (OS) associated with biweekly (Q2W) versus weekly (Q1W) cetuximab dosing regimens for metastatic…”
Get full text

Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer by DeLozier, Amy M, Brown, Jacqueline, Natanegara, Fanni, Zhao, Luping, Cui, Zhanglin Lin, Able, Stephen L, Bowman, Lee, Treat, Joseph, Hess, Lisa M

“…There is a high unmet need for effective treatments for patients with squamous non-small cell lung cancer (NSCLC). Eli Lilly and Company is conducting a phase…”
Get full text

Dosing Patterns for Duloxetine and Predictors of High-Dose Prescriptions in Patients With Major Depressive Disorder: Analysis from a United States Third-Party Payer Perspective by Liu, Xianchen, MD, PhD, Cui, Zhanglin, PhD, Niu, Liyuan, MS, Faries, Douglas E., PhD, Ball, Tamara, MD, Johnstone, Bryan, PhD

“…Abstract Background Major depressive disorder (MDD) is a common illness that affects ∼7% of adults in the United States each year. Duloxetine is a dual…”
Get full text

Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2− Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice by Ring, Alistair, Karuturi, Meghan, Smyth, Emily Nash, Lokhandwala, Tasneem, Sheffield, Kristin M., Willey, Joanne, Lunacsek, Orsolya, Sapunar, Francisco, Cui, Zhanglin Lin, Coutinho, Anna D., Rybowski, Sarah

“…Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast…”
Get full text

Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration by Grabner, Michael, Molife, Cliff, Wang, Liya, Winfree, Katherine B, Cui, Zhanglin Lin, Cuyun Carter, Gebra, Hess, Lisa M

“…The integration of data from disparate sources could help alleviate data insufficiency in real-world studies and compensate for the inadequacies of single data…”
Get full text

Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States by Hess, Lisa M, Grabner, Michael, Wang, Liya, Liepa, Astra M, Li, Xiaohong Ivy, Cui, Zhanglin Lin, Bowman, Lee, Schelman, William R

“…As real-world data resources expand and improve, there will increasingly be opportunities to study the effectiveness of interventions. There is a need to…”
Get full text

Real-world data on overall survival associated with biweekly versus weekly cetuximab among metastatic colorectal cancer (mCRC) patients in the United States by Agg, Himani, Han, Yimei, Cui, Zhanglin Lin

“…Abstract only 33 Background: Cetuximab 250mg/m 2 weekly (Q1W) after an initial dose of 400mg/m 2 is approved for treatment of K-Ras wild-type mCRC. In real…”
Get full text

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol by Hess, Lisa M, Kern, David M, Carter, Gebra Cuyun, Winfree, Katherine, Wang, Liya, Sontag, Angelina, Oton, Ana B

“…Survival outcomes are related to treatment choices in a line of therapy and to treatment sequences across all lines of therapy. The Real-World Treatment…”
Get full text

Propensity score matching and subclassification in observational studies with multi-level treatments by Yang, Shu, Imbens, Guido W., Cui, Zhanglin, Faries, Douglas E., Kadziola, Zbigniew

“…In this article, we develop new methods for estimating average treatment effects in observational studies, in settings with more than two treatment levels,…”
Get full text

Phenotypic Diversity of Modern Chinese and North American Soybean Cultivars by Cui, Zhanglin, Carter, Thomas E., Burton, Joseph W., Wells, Randy

“…Chinese and North American (NA) soybean breeding programs have a 70‐yr history of genetic progress in relative isolation from each other. Because both programs…”
Get full text